Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitex is a brand of vitamin B-complex developed and marketed by Ambee Pharmaceuticals. It is formulated to prevent and treat deficiencies of B-group vitamins, which are essential cofactors in cellular energy metabolism, nervous system function, and red blood cell formation. The product is available in various formulations, including oral capsules, syrup, and an injectable solution (Vitex Injection). The oral formulations typically contain thiamine (vitamin B1), riboflavin (vitamin B2), pyridoxine (vitamin B6), and nicotinamide (vitamin B3), while the parenteral injection formulation is supplemented with D-panthenol (vitamin B5) to provide a higher-potency therapeutic option for acute deficiency states or patients with impaired gastrointestinal absorption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on vitamin B complex (Ambee Pharmaceuticals).